These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 1909711

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Mouse model of oral infection with virulent type A Francisella tularensis.
    KuoLee R, Zhao X, Austin J, Harris G, Conlan JW, Chen W.
    Infect Immun; 2007 Apr; 75(4):1651-60. PubMed ID: 17242058
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals.
    Sjöstedt A, Sandström G, Tärnvik A.
    J Clin Microbiol; 1990 Jan; 28(1):43-8. PubMed ID: 1688874
    [Abstract] [Full Text] [Related]

  • 46. Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis.
    Eneslätt K, Rietz C, Rydén P, Stöven S, House RV, Wolfraim LA, Tärnvik A, Sjöstedt A.
    Eur J Immunol; 2011 Apr; 41(4):974-80. PubMed ID: 21442618
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Vaccination strategies for Francisella tularensis.
    Isherwood KE, Titball RW, Davies DH, Felgner PL, Morrow WJ.
    Adv Drug Deliv Rev; 2005 Jun 17; 57(9):1403-14. PubMed ID: 15919131
    [Abstract] [Full Text] [Related]

  • 49. M-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensis.
    Cunningham AL, Guentzel MN, Yu JJ, Hung CY, Forsthuber TG, Navara CS, Yagita H, Williams IR, Klose KE, Eaves-Pyles TD, Arulanandam BP.
    PLoS One; 2016 Jun 17; 11(4):e0153402. PubMed ID: 27100824
    [Abstract] [Full Text] [Related]

  • 50. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.
    Pammit MA, Raulie EK, Lauriano CM, Klose KE, Arulanandam BP.
    Infect Immun; 2006 Apr 17; 74(4):2063-71. PubMed ID: 16552035
    [Abstract] [Full Text] [Related]

  • 51. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
    McMurry JA, Gregory SH, Moise L, Rivera D, Buus S, De Groot AS.
    Vaccine; 2007 Apr 20; 25(16):3179-91. PubMed ID: 17291638
    [Abstract] [Full Text] [Related]

  • 52. Toll-like receptor 2 controls the gamma interferon response to Francisella tularensis by mouse liver lymphocytes.
    Hong KJ, Wickstrum JR, Yeh HW, Parmely MJ.
    Infect Immun; 2007 Nov 20; 75(11):5338-45. PubMed ID: 17785474
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages.
    Polsinelli T, Meltzer MS, Fortier AH.
    J Immunol; 1994 Aug 01; 153(3):1238-45. PubMed ID: 8027551
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Natural killer and CD8 T cells dominate the response by human peripheral blood mononuclear cells to inactivated Francisella tularensis live vaccine strain.
    Gosselin EJ, Gosselin DR, Lotz SA.
    Hum Immunol; 2005 Oct 01; 66(10):1039-49. PubMed ID: 16386645
    [Abstract] [Full Text] [Related]

  • 58. Nature of protective immunity to Francisella tularensis.
    Tärnvik A.
    Rev Infect Dis; 1989 Oct 01; 11(3):440-51. PubMed ID: 2665002
    [Abstract] [Full Text] [Related]

  • 59. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
    Wu TH, Hutt JA, Garrison KA, Berliba LS, Zhou Y, Lyons CR.
    Infect Immun; 2005 May 01; 73(5):2644-54. PubMed ID: 15845466
    [Abstract] [Full Text] [Related]

  • 60. [ROLE OF VARIOUS ANTIGENIC PREPARATIONS OF FRANCISELLA TULARENSIS IN FORMATION OF ALLERGY REACTION IN HUMANS AND ANIMALS].
    Onoprienko NN, Aronova NV, Pavlovich NV.
    Zh Mikrobiol Epidemiol Immunobiol; 2016 May 01; (1):22-9. PubMed ID: 27029112
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.